At this point the launch is a very positive move for Momenta.
How it plays out from is a little sketchy but it should be in Momenta's favor (proving that once again the recent ATM's and Stock sales were a massive mistake. The CFO should be given his walking papers).
With Mylan not receiving FDA approval yet is extremely positive and I expect TEVA to take them out prior to Approval. That will mean that Natco will lose it's sponsor and will delay the approval further.
I do expect the FDA to approve someone else in the long term and then Momenta will be back on first base, but as of now it's party on time.
Market Data 
Markets 
AI
